Evidence

Test the formulation. Then test it again.

zolvia.'s validation programme follows an active from aqueous performance and digestion models through to human pharmacokinetic measurement.

01

Bioaccessibility

A distinct validation layer used to understand performance before and after formulation.

02

Digestion

A distinct validation layer used to understand performance before and after formulation.

03

Solubility

A distinct validation layer used to understand performance before and after formulation.

04

Stability

A distinct validation layer used to understand performance before and after formulation.

Mean plasma curcumin concentration after a single 500 mg dose. Error bars are retained from the source chart.Original study figure, shown complete and unaltered.
Published report

z-curcumin human pharmacokinetic study

A randomised, double-blind, single-dose comparison of powder z-curcumin, aqueous-liquid z-curcumin and native curcumin extract in healthy adults.

  • 500 mg dose
  • 5 participants per arm reported
  • 6-hour observation window
  • Atlantia Food Clinical Trials, Cork
Read the study summary

The available report describes pharmacokinetic absorption measurements. It is not presented as evidence of a health outcome, nor as a peer-reviewed or registered trial.

Ready to make your ingredients perform in the finished product?

Speak with our team about your ingredient, product and application — and see how the platform can support your workflow.